Taken together, our data indicate that viperin is a major driver of cancer metabolic reprogramming and that the Fe-S cluster binding motif of viperin is necessary for its function, suggesting a potential target for the development of anticancer therapeutics. The gene discussed is RSAD2; the disease is cancer.